CHICAGO - GE HealthCare (NASDAQ: NASDAQ:GEHC) announced today the FDA 510(k) clearance of its new Portrait VSM, a portable vital signs monitor designed to improve clinical workflows and patient care. The device is intended to help healthcare professionals detect patient deterioration earlier and make timely treatment decisions.
The Portrait VSM is part of GE HealthCare's Portrait Ecosystem, a suite of patient monitoring solutions. It provides accurate measurements of blood pressure, pulse rate, oxygen saturation, body temperature, and respiratory rate. The monitor uses the SuperSTAT non-invasive blood pressure algorithm to enhance the precision of readings.
With wireless connectivity and electronic medical record (EMR) integration, Portrait VSM aims to streamline the spot check process and reduce the manual effort involved in patient monitoring. The device can connect with Portrait Mobile, a wireless and wearable continuous monitoring solution, to integrate patient data into a unified workflow. This allows clinicians to capture a complete set of vital sign measurements more efficiently during clinical rounds.
The traditional method of spot checking vital signs every 4-6 hours can miss early signs of patient deterioration. Portrait VSM addresses this by combining spot check capability with continuous monitoring. The monitor's features include customized Early Warning Scores (EWS) to help clinicians recognize early signs of deterioration and intervene in a timely manner.
Neal Sandy, general manager of monitoring solutions at GE HealthCare, emphasized the importance of efficient patient monitoring technology in providing confident care. The company's study on healthcare challenges found that nearly half of clinicians experience difficulties with medical technologies not integrating seamlessly.
Portrait VSM also offers a Round Advisor feature to help care teams prioritize spot checks for multiple patients. GE HealthCare's monitoring solutions have been globally recognized for their design, receiving prestigious awards for Portrait Mobile and CARESCAPE Canvas.
This announcement is based on a press release statement from GE HealthCare. For further details on the Portrait VSM and other monitoring solutions, visit GE HealthCare's official product page.
InvestingPro Insights
Amidst recent advancements, GE HealthCare (NASDAQ: GEHC) has been gaining attention not only for its innovative medical technologies but also for its financial performance. According to InvestingPro data, GE HealthCare boasts a robust market capitalization of 39.35 billion USD, reflecting the company's significant presence in the healthcare industry. Additionally, the company has demonstrated a solid revenue growth of 6.6% over the last twelve months as of Q4 2023, underscoring its ability to expand its market share and financial strength.
In terms of profitability, GE HealthCare has shown a strong return over the last three months with a 15.99% price total return, and an even more impressive 36.77% over the last six months, indicating a large price uptick in the market. This performance is echoed by their Price / Book multiple of 5.52, which is high, suggesting that investors are willing to pay a premium for the company's shares based on its net asset value.
Two InvestingPro Tips highlight GE HealthCare's position in the market: the company is a prominent player in the Healthcare Equipment & Supplies industry and is expected to be profitable this year, as indicated by analysts. This is a critical factor for investors who are looking for companies with a strong foothold in their respective sectors and a positive outlook on profitability. For readers interested in a deeper dive into GE HealthCare's potential, there are more InvestingPro Tips available, providing comprehensive analysis and guidance on the company's financial health and stock performance.
For those considering an investment in GE HealthCare, or simply wishing to stay informed on the company's financial metrics, the InvestingPro platform offers detailed insights and additional tips. Use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, and gain access to valuable information that could help guide your investment decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.